Loading
Journal of AIDS and HIV Treatment
ISSN: 2688-7436
2025
Volume 7, Issue 1, p1-53
Articles published in this issue are Open Access and licensed under Creative Commons Attribution License (CC BY NC) where the readers can reuse, download, distribute the article in whole or part by mentioning proper credits to the authors.
Perceptions and Knowledge of HIV/AIDS Among Black Women: An Exploratory Study
Erica Campbell, Nizejai Anderson
Black women in the United States face disproportionate rates of HIV/AIDS, with higher new infection rates and poorer health outcomes compared to other racial and gender groups. This study seeks to explore the perceptions and knowledge surrounding HIV/AIDS among Black women, to contribute to social work and public health knowledge.
J AIDS HIV Treat, 2025, Volume 7, Issue 1, p1-12 | DOI: 10.33696/AIDS.7.055
Disclosing Sexual Partner's HIV/AIDS Status before Sexual Activity: A Cross-sectional Study on Factors Affecting Confidence
Mbwiga Sote Aloni, Orestes Silverius Kapinga
Background: Human immunodeficiency virus (HIV) can be transmitted through the exchange of body fluids with persons who are HIV positive. For the sake of prevention and care, disclosing the partner’s HIV status is crucial. Most sexual partners face difficulties in inquiring about the HIV status of their sexual partners.
J AIDS HIV Treat, 2025, Volume 7, Issue 1, p13-21 | DOI: 10.33696/AIDS.7.056
Determination of Anthropometric and Immune Inflammatory Responses in Patients on Dolutegravir Based Antiretroviral Therapy at University of Nigeria Teaching Hospital Ituku-Ozalla
Chima O. Onwuka-Kalu, Ejike F. Chukwurah
Dolutegravir, an integrase strand transfer inhibitor has been found to affect anthropometric indices. A total of 40 subjects comprising 19 male and 21 female were recruited for the study and apparently healthy sex and age matched individuals who tested sero-negative to HIV screening were used as controls. Standard weighing scale and measuring tape were used to determine body mass index (BMI) and Waist-to-Hip Ratio (WHR).
J AIDS HIV Treat, 2025, Volume 7, Issue 1, p22-26 | DOI: 10.33696/AIDS.7.057
The Performance of a New Multidimensional Frailty Index in Comparison to the Frailty Phenotype to Assess Frailty in People Living with HIV 50 Years of Age and Older in an Urban HIV Clinic
Uzoamaka A. Eke, Katie Wasserstein, Carolyn Susman, Ahizechukwu C. Eke, Kareshma Mohanty, Sarah Schmalzle, Nicole Viviano, Jennifer D Hoffmann, Neha S. Pandit, Robyn Palmeiro, Judith Lee, Alice S Ryan, Kristen A. Stafford, Ann Gruber-Baldini
Background: Frailty is increasingly recognized in older people living with HIV (PLWH), but optimal diagnostics are yet to be determined. Frailty indices (FI) represent an accumulation of health deficits shown to correlate better with mortality and adverse effects of aging than the frailty phenotype or chronological age. Methods: This is a retrospective cohort study of frailty assessments in PLWH aged ≥ 50 years in a multidisciplinary urban HIV clinic. Frailty was assessed using Frailty Phenotype (FP) and a new 40-variable clinical composite FI derived from routine clinical and laboratory data (CCFI).
J AIDS HIV Treat, 2025, Volume 7, Issue 1, p27-37 | DOI: 10.33696/AIDS.7.058
- Abstract |
- Full Text |
- Cite |
- Supplementary File
Socio-Demographic Characteristics of Newly Diagnosed People Living with HIV Initiating Antiretroviral Treatment at the Adult Day Hospital of Bobo-Dioulasso Over a Five-year Period
Yacouba Sawadogo, Mafama Siribié, Aicha Savadogo, Hayazouma Hadiaratou Inès Hakiekou, Jessica Julie Chantal Samba, Noutin Fernand Michodigni, Cheick Ahmed Ouattara, Jacques Zoungrana, Armel Poda, Abdoul-Salam Ouédraogo
Background: HIV infection is a major public health problem in sub-Saharan Africa, particularly in Burkina Faso. This study aimed to describe the socio-demographic characteristics of newly person living with HIV initiating antiretroviral treatment at the Adult Day Hospital of Bobo-Dioulasso over a five-year period.
J AIDS HIV Treat, 2025, Volume 7, Issue 1, p47-53 | DOI: 10.33696/AIDS.7.060
Recommended Articles
Socio-Demographic Characteristics of Newly Diagnosed People Living with HIV Initiating Antiretroviral Treatment at the Adult Day Hospital of Bobo-Dioulasso Over a Five-year Period
Background: HIV infection is a major public health problem in sub-Saharan Africa, particularly in Burkina Faso. This study aimed to describe the socio-demographic characteristics of newly person living with HIV initiating antiretroviral treatment at the Adult Day Hospital of Bobo-Dioulasso over a five-year period.
Primary Lymph Node Kaposi's Sarcoma in Two HIV Positive Patients Presenting with Generalized Lymphadenopathy and Pancytopenia in a Third Level Hospital in Guatemala
We present two unique cases in which two HIV positive patients with generalized lymphadenopathy and pancytopenia without any skin lesions were diagnosed with primary lymph node Kaposi´s Sarcoma after excisional biopsy of an inguinal lymph node.
CCR5 Inhibitors and HIV-1 Infection
Cellular components are attractive targets for antiviral therapy because they do not mutate as readily as do viral proteins do [1-3]. The identification of CCR5 as an HIV-1 coreceptor [4-7], facilitated by the discovery of the antiviral activities of CCR5 ligand ?-chemokines [8], resulted in the development of new viral entry inhibitors to block CCR5 binding, including both- small molecules and CCR5 antibodies
The Impact of Marginalization on the Continuum of Care Treatment Model on African American Communities in the Southern United States
Recently, I was asked to speak at the National Academy of Public Administration (NAPA) Conference about my experiences serving as an ethnographic consultant on the National HIV Behavioral Surveillance System (NHBS1 ) Study.
Recent Progress in Preclinical HIV-1 Vaccine Research
Since isolation in humans in 1983 [1,2], HIV-1 has developed into a global pandemic. But an effective HIV-1 vaccine has not been succeeded despite multiple human vaccine trials performed [3,4]. Challenges to an effective vaccine arise from intrinsic virological and immunological features of HIV-1 [3-8].
Anti-HIV-1 Activity of Crocodylus mindorensis (Philippine Crocodile) Serum in Cell-free and Cell-associated Virus Interactions to Human Peripheral Blood Mononuclear Cells
Highly-Active Antiretroviral Therapy (HAART) is the recommended treatment and management strategy for HIV infection. Although the existing antiretroviral drugs are indispensably significant in improving the quality and extending the lives of HIV/ AIDS individuals, the drugs still have many limitations including development of resistance, production of toxicity, and their limited availability.
Assessment of Attitudes toward HIV and AIDS among Undergraduate Students at a Historically Black University
HIV is no longer only a public health challenge, but also a global threat with a devastating negative impact that has claimed over 35 million lives globally. In 2017, about 36.9 million people live with HIV, and 1.8 million people becoming newly infected with the disease globally [1].
Health Workers’ Perspectives on the Outcomes, Enablers, and Barriers to the Implementation of HIV “Test and Treat” Guidelines in Abuja, Nigeria
HIV/AIDS continues to be a major public health disease accounting for 35 million deaths across the world. In 2016 alone, there were 1.8 million new HIV infections and 1 million deaths worldwide.
HIV-1 Treatment Failure among Population Taking Antiretroviral Therapy in Ethiopia
For more than 35 years, the world has grappled with an AIDS epidemic that has claimed an estimated 35.0 million [28.9 million-41.5 million] lives and at its peak threatened global stability and security.
Rate and Predictors of Treatment Failure among Pediatric Population Taking Highly Active Antiretroviral Therapy in Ethiopia
The global scaling up of treatment and care for people living with Human Immunodeficiency Virus (PLHIV) has led to a 43% decline in new HIV pediatric infections since 2003, with 330,000 newly infected children in 2011.
Development of an Ultrasensitive HIV-1 DNA Detection Assay Based on an Automated πCode End-Point PCR System
Currently, around 60-75% of the HIV positive patients in developed countries on anti-retroviral therapy (ART) have undetectable plasma viral load using current diagnostic PCR assays.
Patient-Reported Health Outcomes among HIV-Infected Patients on Antiretroviral Therapy in a Tertiary Hospital in Dar Es Salaam, Tanzania: A Cross Sectional Study
The use of antiretroviral therapy (ART) has resulted into HIV-infected patients living longer than it was the case in the pre-ART era [1]. Surviving patients are concerned not only with the treatment ability to extend their lives but also that their quality of life is improved on the course.
Black Women's Contribution to the HIV/AIDS Fight
After thousands of years of gender conflicts, the world now stands at the beginning of the feminine era, when women will rise to their proper standing, and the entire world will experience the harmony between men and women.
Use of Humanized Mouse Models for Studying HIV-1 Infection, Pathogenesis and Persistence
Different humanized mouse models have been introduced to enable HIV-1 research in vivo, which has been made possible by the development of immunodeficient mouse strains.
Metabolic Syndrome in HIV Infected Children Receiving Free HAART at a Centre of Excellence in HIV Care in Northern India
Implementation of Highly Active Antiretroviral Therapy (HAART) for patients with HIV has led to the dramatic reduction in AIDS related mortality in both children and adults [1]. With their longer life expectancy and improved quality of life, effects of ageing and other environmental factors are predisposing them to non-AIDS related morbidities, with cardiovascular diseases emerging as an important threat.
Unveiling an Atypical Response to HIV-1 Infection by the Patient Carrier of the Beta-S Globin Gene and Duffy Antigen Gene Double Mutation
It is known and well documented that genetic selective pressures occur from Plasmodium falciparum, P. vivax or P. knowlesi infection of red blood cells, such led to the selection of their cell membrane antigens, hemoglobin and enzymes thus associated to several mutation including, among others.
Older Versus Younger Men Who Have Sex with Men: Awareness of and Potential Barriers to the Use of Pre-Exposure Prophylaxis (PrEP) Medication to Prevent the Transmission of HIV
Men who have sex with other men (MSM) comprise the single largest group of individuals contracting HIV in the United States, accounting for more than one-half of all new HIV diagnoses.
Trend of HIV Infection in a Specialized Medical Unit, 2007- 2016
The human immunodeficiency virus (HIV) has caused one of the pandemics that has most affected the world population [1], and continues to be a serious problem, since to date it has not been possible to eradicate or prevent totally new cases.
AIDS Related Histoplasmosis, Treatment and Prophylaxis: the Mycology Unit of FJ Muniz Hospital Experience
Classic histoplasmosis is a systemic endemic mycosis due to the dimorphic fungus Histoplasma capsulatum var. capsulatum. This microorganism lives as mold in rich nitrogen soil in temperate and humid regions.
Anaphylaxis Drug Reaction after Initiation of Bictegravir
A 44-year old Ethiopian female with a history of HIV and latent tuberculosis treated with three months of rifampin presented to the Ruth M Rothstein CORE Center complaining of pruritic rash that started the previous night.